acris combi risedronate sodium 35 mg film-coated tablets and calcium carbonate 1250 mg tablets blister pack
alphapharm pty ltd - calcium carbonate,risedronate sodium -
actonel ec combi risedronate sodium 35mg enteric-coated tablet and calcium carbonate 1250mg tablet blister pack
theramex australia pty ltd - calcium carbonate,risedronate sodium -
actonel ec combi d risedronate sodium 35mg enteric-coated tablet / calcium carbonate 2500 mg and colecalciferol 22 microgram gra
theramex australia pty ltd - calcium carbonate,colecalciferol,risedronate sodium -
actonel combi risedronate sodium 35mg and calcium carbonate 1250mg tablet blister pack
theramex australia pty ltd - calcium carbonate,risedronate sodium -
atelvia combi d risedronate sodium 35mg tablet / supplemental 2500 mg calcium carbonate/22 microgram colecalciferol sachet compo
theramex australia pty ltd - calcium carbonate,colecalciferol,risedronate sodium -
actonel combi d risedronate sodium 35mg tablet / supplemental 2500 mg calcium carbonate/22 microgram colecalciferol sachet compo
theramex australia pty ltd - calcium carbonate,colecalciferol,risedronate sodium -
atelvia combi risedronate sodium 35mg and calcium carbonate 1250mg tablet blister pack
theramex australia pty ltd - calcium carbonate,risedronate sodium -
atelvia ec combi risedronate sodium 35mg enteric-coated tablet and calcium carbonate 1250mg tablet blister pack
theramex australia pty ltd - calcium carbonate,risedronate sodium -
atelvia ec combi d risedronate sodium 35mg enteric-coated tablet / calcium carbonate 2500 mg & colecalciferol 22 micrograms gran
theramex australia pty ltd - calcium carbonate,colecalciferol,risedronate sodium -
risedronate sodium- risedronate sodium tablet, film coated
mylan pharmaceuticals inc. - risedronate sodium (unii: ofg5exg60l) (risedronic acid - unii:km2z91756z) - risedronate sodium 5 mg - risedronate sodium tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women. in postmenopausal women with osteoporosis, risedronate reduces the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures [see clinical studies (14.1, 14.2) ]. risedronate sodium tablets are indicated for treatment to increase bone mass in men with osteoporosis. risedronate sodium tablets are indicated for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoid treatment (daily dosage of greater than or equal to 7.5 mg of prednisone or equivalent) for chronic diseases. patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin d. risedronate sodium tablets are indicated for treatment of paget’s disease of bone in men and women. the optimal duration of use has not been determined. the safety and effectiveness of risedronate